Global Traumatic Brain Injuries Treatment Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024

Industry : Healthcare Date : March 6th, 2018
Tutorials Get 15% Discount on First Report

The global traumatic brain injuries treatment market is expected to grow steadily from USD 112.6 billion in 2017 to USD 156.8 billion in 2024, at a CAGR of 4.8% from 2018 to 2024. Factors propelling the growth of traumatic brain injuries treatment market are growing number of research and development activities, increasing number of road accidents, and growing number of vulnerable aging population.  The years used for the assessment are as follows;

Historical year: 2014, 2015, 2016

Base year: 2017

Forecast period: 2018 – 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year Impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the total traumatic brain injuries treatment market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global traumatic brain injuries treatment market
  • Finalizing the overall size and share of the global traumatic brain injuries treatment market

OBJECTIVES:

  • To classify the global traumatic brain injuries treatment market into segments on the basis of age, sex, external causes, treatment, route of drug administration, end-user, and region  analyze their growth prospects individually
  • To analyze market trends, opportunities, drivers, and restraints associated with the traumatic brain injuries treatment market
  • To study market response with respect to the mergers and acquisitions in the industry
  • To profile key companies operating in the traumatic brain injuries treatment market and provide their competitive landscape

 

MARKET SCOPE

The research scope for Traumatic Brain Injuries Treatment Market is as follows:

By Age

  • Children
  • Teenager
  • Elder

By Sex

  • Male
  • Female

By External Causes

  • Falls
  • Motor vehicle–traffic injury
  • Sports
  • Other

By Treatment

  • Surgery
  • Drugs
    • Anti-Anxiety Agents
    • Anti-Depressants
    • Anti-Psychotics
    • Analgesics
    • Anti-Convulsants
    • Anti-Coagulants
    • Other

By Route of Drug Administration

  • Parenteral
  • Oral

By End-User

  • Hospitals
  • Neurologist Centers
  • Pharmacy
  • Other

By Region

  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

The global traumatic brain injuries treatment market is expected to grow steadily from USD 112.6 billion in 2017 to USD 156.8 billion in 2024, at a CAGR of 4.8% from 2018 to 2024. Factors propelling the growth of traumatic brain injuries treatment market include increasing number of road accidents and growing number of vulnerable aging population. Moreover, growing research activities on diagnosis management and huge new pipeline of drugs are further boosting the growth of the global traumatic brain injuries treatment market. On the other hand, the high cost of treatment and monitoring device may hinder the growth of the market.

A severe damage caused to the brain by a jolt or bump can result in traumatic brain injury (TBI). Millions of people suffer from brain injuries every year, and half of them rush to get urgent medical assistance due to critical damages. If not treated on time, such injuries can lead to permanent brain damage or death. Majority of traumatic brain injury are from road accidents, followed by combat zones.

Based on the Age, the elder age segment held the major share of global traumatic brain injuries treatment market owing to increasing incidence of falls and road accidents. On the basis of Treatment, the drug segment holds major share of the global traumatic brain injuries treatment market and expected to grow at a significant rate during the forecast period. Factor are minor traumatic brain injuries usually no requirement to surgery, and new clinical trial are ongoing, coupled with major key player are investing in development of new drugs.

Geographically, North America holds the major share of global traumatic brain injuries treatment market owing to growing number of TBI (traumatic brain injury) patients, and increasing research and development activity on diagnosis management. Europe is the second largest market share of the global traumatic brain injuries treatment market. Growing incidence in elderly patients, and increasing road traffic accidents, coupled with the government initiatives to funding for traumatic brain injuries project.

Key players profiled in the global traumatic brain injuries treatment market are Neuren Pharmaceuticals Ltd, TEVA Pharmaceutical Industries Ltd., Grace Laboratories LLC., NeuroScience Pharmaceuticals, Tenax Therapeutics, IschemixInc, Vasopharm GmbH, Amarantus BioScience Holdings, Silver Creek Pharmaceuticals Inc, Stemedica Cell Technologies Inc, Banayan Biomarkers Inc., among other.

Traumatic brain injuries market

TABLE OF CONTENTS

CHAPTER 1. Market Scope and Methodology

1.1. Market Definition

1.2. Market Segmentation

1.2.1. Market Breakdown By, Age

1.2.2. Market Breakdown By, Sex

1.2.3. Market Breakdown By, External Causes

1.2.4. Market Breakdown, By Treatment

1.2.5. Market Breakdown, By Route of Drug Administration

1.2.6. Market Breakdown, By End-User

1.2.7. Market Breakdown, By Region

1.3. Research Methodology

1.3.1. Initial Data Search

1.3.2. Secondary Research

1.3.3. Primary Research

1.3.4. Scope and Assumptions

1.4. Sources

1.5. Executive Summary

CHAPTER 2. Market Outlook

2.1. Introduction

2.2. Market Outlook

2.2.1. Opportunities

2.2.1.1. Advances in molecular medicine including gene and stem cell therapy

2.2.1.2. Government and private funding support to the traumatic brain injury treatment

2.2.2. Trends

2.2.2.1. Clinical trials are currently underway for treatment of traumatic brain injuries

2.2.2.2. Advance research and development activities

2.2.3. Growth Drivers

2.2.3.1. Growing investments in research & development activities

2.2.3.2. Increasing number of accident

2.2.3.3. Detection devices approvals

2.2.3.4. Increasing number of aging population

2.2.4. Impact Analysis of Drivers on Future Forecast of the Market

2.2.5. Restraints of the Market

2.2.5.1. High cost of treatment and monitoring device

2.2.6. Impact Analysis of Restraints on Future Forecast of the Market

CHAPTER 3. Industry Analysis

3.1. Value Chain Analysis

3.2. Competitive Analysis

3.2.1. Company Market Share Analysis

3.2.2. Porter’s Five Forces Analysis

CHAPTER 4. Global Traumatic Brain Injuries Treatment Market Size and Forecast (2014 – 2024)

4.1. Global Traumatic Brain Injuries Treatment Market, By Age

4.1.1. Children

4.1.2. Teenager

4.1.3. Elder

4.2. Global Traumatic Brain Injuries Treatment Market, By Sex

4.2.1. Male

4.2.2. Female

4.3. Global Traumatic Brain Injuries Treatment Market, By External Causes

4.3.1. Falls

4.3.2. Motor vehicle–traffic injury

4.3.3. Sports

4.3.4. Other

4.4. Global Traumatic Brain Injuries Treatment Market, By Treatment

4.4.1. Surgery

4.4.2. Drugs

4.4.2.1. Anti-Anxiety Agents

4.4.2.2. Anti-Depressants

4.4.2.3. Anti-Psychotics

4.4.2.4. Analgesics

4.4.2.5. Anti-Convulsants

4.4.2.6. Anti-Coagulants

4.4.2.7. Other

4.5. Global Traumatic Brain Injuries Treatment Market, By Route of Drug Administration

4.5.1. Parenteral

4.5.2. Oral

4.6. Global Traumatic Brain Injuries Treatment Market, By End-User

4.6.1. Hospitals

4.6.2. Neurologist Centers

4.6.3. Pharmacy

4.6.4. Other

4.7. Global Traumatic Brain Injuries Treatment Market, By Region

4.7.1. North America

4.7.2. Latin America

4.7.3. Europe

4.7.4. Asia-Pacific

4.7.5. Middle East and Africa

CHAPTER 5. Global Traumatic Brain Injuries Treatment Market, By Geography

5.1. North America Traumatic Brain Injuries Treatment Market

5.1.1. North America Traumatic Brain Injuries Treatment Market, By Age (USD Billion)

5.1.2. North America Traumatic Brain Injuries Treatment Market, By Sex (USD Billion)

5.1.3. North America Traumatic Brain Injuries Treatment Market, By External Causes (USD Billion)

5.1.4. North America Traumatic Brain Injuries Treatment Market, By Treatment (USD Billion)

5.1.5. North America Traumatic Brain Injuries Treatment Market, By Route of Drug Administration (USD Billion)

5.1.6. North America Traumatic Brain Injuries Treatment Market, By End-User (USD Billion)

5.1.7. North America Traumatic Brain Injuries Treatment Market, By Country

5.1.7.1. The U.S.

5.1.7.2. Canada

5.1.7.3. Mexico

5.1.7.4. Rest of North America

5.1.7.4.1. Rest of North America Traumatic Brain Injuries Treatment Market, By Age (USD Billion)

5.1.7.4.2. Rest of North America Traumatic Brain Injuries Treatment Market, By Sex (USD Billion)

5.1.7.4.3. Rest of North America Traumatic Brain Injuries Treatment Market, By External Causes (USD Billion)

5.1.7.4.4. Rest of North America Traumatic Brain Injuries Treatment Market, By Treatment (USD Billion)

5.1.7.4.5. Rest of North America Traumatic Brain Injuries Treatment Market, By Route of Drug Administration (USD Billion)

5.1.7.4.6. Rest of North America Traumatic Brain Injuries Treatment Market, By End-User (USD Billion)

5.2. Latin America Traumatic Brain Injuries Treatment Market

5.2.1. Latin America Traumatic Brain Injuries Treatment Market, By Age (USD Billion)

5.2.2. Latin America Traumatic Brain Injuries Treatment Market, By Sex (USD Billion)

5.2.3. Latin America Traumatic Brain Injuries Treatment Market, By External Causes (USD Billion)

5.2.4. Latin America Traumatic Brain Injuries Treatment Market, By Treatment (USD Billion)

5.2.5. Latin America Traumatic Brain Injuries Treatment Market, By Route of Drug Administration (USD Billion)

5.2.6. Latin America Traumatic Brain Injuries Treatment Market, By End-User (USD Billion)

5.2.7. Latin America Traumatic Brain Injuries Treatment Market By Country

5.2.7.1. Argentina

5.2.7.2. Brazil

5.2.7.3. Colombia

5.2.7.4. Rest of Latin America

5.2.7.4.1. Rest of Latin America Traumatic Brain Injuries Treatment Market, By Age (USD Billion)

5.2.7.4.2. Rest of Latin America Traumatic Brain Injuries Treatment Market, By Sex (USD Billion)

5.2.7.4.3. Rest of Latin America Traumatic Brain Injuries Treatment Market, By External Causes (USD Billion)

5.2.7.4.4. Rest of Latin America Traumatic Brain Injuries Treatment Market, By Treatment (USD Billion)

5.2.7.4.5. Rest of Latin America Traumatic Brain Injuries Treatment Market, By Route of Drug Administration (USD Billion)

5.2.7.4.6. Rest of Latin America Traumatic Brain Injuries Treatment Market, By End-User (USD Billion)

5.3. Europe Traumatic Brain Injuries Treatment Market

5.3.1. Europe Traumatic Brain Injuries Treatment Market, By Age (USD Billion)

5.3.2. Europe Traumatic Brain Injuries Treatment Market, By Sex (USD Billion)

5.3.3. Europe Traumatic Brain Injuries Treatment Market, By External Causes (USD Billion)

5.3.4. Europe Traumatic Brain Injuries Treatment Market, By Treatment (USD Billion)

5.3.5. Europe Traumatic Brain Injuries Treatment Market, By Route of Drug Administration (USD Billion)

5.3.6. Europe Traumatic Brain Injuries Treatment Market, By End-User (USD Billion)

5.3.7. Europe Traumatic Brain Injuries Treatment Market, By Country

5.3.7.1. Germany

5.3.7.2. France

5.3.7.3. The U.K.

5.3.7.4. Italy

5.3.7.5. Spain

5.3.7.6. France

5.3.7.7. Monaco

5.3.7.8. Estonia

5.3.9. Rest of Europe

5.3.9.1. Rest of Europe Traumatic Brain Injuries Treatment Market, By Age (USD Billion)

5.3.9.2. Rest of Europe Traumatic Brain Injuries Treatment Market, By Sex (USD Billion)

5.3.9.3. Rest of Europe Traumatic Brain Injuries Treatment Market, By External Causes (USD Billion)

5.3.9.4. Rest of Europe Traumatic Brain Injuries Treatment Market, By Treatment (USD Billion)

5.3.9.5. Rest of Europe Traumatic Brain Injuries Treatment Market, By Route of Drug Administration (USD Billion)

5.3.9.6. Rest of Europe Traumatic Brain Injuries Treatment Market, By End-User (USD Billion)

5.4. Asia-Pacific Traumatic Brain Injuries Treatment Market

5.4.1. Asia-Pacific Traumatic Brain Injuries Treatment Market, By Age (USD Billion)

5.4.2. Asia-Pacific Traumatic Brain Injuries Treatment Market, By Sex (USD Billion)

5.4.3. Asia-Pacific Traumatic Brain Injuries Treatment Market, By External Causes (USD Billion)

5.4.4. Asia-Pacific Traumatic Brain Injuries Treatment Market, By Treatment (USD Billion)

5.4.5. Asia-Pacific Traumatic Brain Injuries Treatment Market, By Route of Drug Administration (USD Billion)

5.4.6. Asia-Pacific Traumatic Brain Injuries Treatment Market, By End-User (USD Billion)

5.4.7. Asia-Pacific Traumatic Brain Injuries Treatment Market, By Country

5.4.7.1. China

5.4.7.2. Japan

5.4.7.3. Singapore

5.4.7.4. Australia

5.4.7.5. India

5.4.7.6. South Korea

5.4.7.7. New Zealand

5.4.7.8. Rest of Asia-Pacific

5.4.7.8.1. Rest of Asia-Pacific Traumatic Brain Injuries Treatment Market, By Age (USD Billion)

5.4.7.8.2. Rest of Asia-Pacific Traumatic Brain Injuries Treatment Market, By Sex (USD Billion)

5.4.7.8.3. Rest of Asia-Pacific Traumatic Brain Injuries Treatment Market, By External Causes (USD Billion)

5.4.7.8.4. Rest of Asia-Pacific Traumatic Brain Injuries Treatment Market, By Treatment (USD Billion)

5.4.7.8.5. Rest of Asia-Pacific Traumatic Brain Injuries Treatment Market, By Route of Drug Administration (USD Billion)

5.4.7.8.6. Rest of Asia-Pacific Traumatic Brain Injuries Treatment Market, By End-User (USD Billion)

5.5. Middle East and Africa Traumatic Brain Injuries Treatment Market

5.5.1. Middle East and Africa Traumatic Brain Injuries Treatment Market, By Age (USD Billion)

5.5.2. Middle East and Africa Traumatic Brain Injuries Treatment Market, By Sex (USD Billion)

5.5.3. Middle East and Africa Traumatic Brain Injuries Treatment Market, By External Causes (USD Billion)

5.5.4. Middle East and Africa Traumatic Brain Injuries Treatment Market, By Treatment (USD Billion)

5.5.5. Middle East and Africa Traumatic Brain Injuries Treatment Market, By Route of Drug Administration (USD Billion)

5.5.6. Middle East and Africa Traumatic Brain Injuries Treatment Market, By End-User (USD Billion)

5.5.7. Middle East and Africa Traumatic Brain Injuries Treatment Market, By Country

5.5.7.1. Israel

5.5.7.2. Saudi Arabia

5.5.7.3. Ethiopia

5.5.7.4. Iran

5.5.7.5. Rest of Middle East and Africa

5.5.7.5.1. Rest of Middle East and Africa Traumatic Brain Injuries Treatment Market, By Age (USD Billion)

5.5.7.5.2. Rest of Middle East and Africa Traumatic Brain Injuries Treatment Market, By Sex (USD Billion)

5.5.7.5.3. Rest of Middle East and Africa Traumatic Brain Injuries Treatment Market, By External Causes (USD Billion)

5.5.7.5.4. Rest of Middle East and Africa Traumatic Brain Injuries Treatment Market, By Treatment (USD Billion)

5.5.7.5.5. Rest of Middle East and Africa Traumatic Brain Injuries Treatment Market, By Route of Drug Administration (USD Billion)

5.5.7.5.6. Rest of Middle East and Africa Traumatic Brain Injuries Treatment Market, By End-User (USD Billion)

CHAPTER 6. Key Players and Strategic Developments

6.1. Neuren Pharmaceuticals Ltd

6.1.1. Business Overview

6.1.2. Product and Service Offering

6.1.3. Financial Overview

6.1.4. SWOT Analysis

6.1.5. Strategic Developments

6.2. TEVA Pharmaceutical Industries Ltd.

6.2.1. Business Overview

6.2.2. Product and Service Offering

6.2.3. Financial Overview

6.2.4. SWOT Analysis

6.2.5. Strategic Developments

6.3. Grace Laboratories LLC.

6.3.1. Business Overview

6.3.2. Product and Service Offering

6.3.3. Financial Overview

6.3.4. SWOT Analysis

6.3.5. Strategic Developments

6.4. NeuroScience Pharmaceuticals

6.4.1. Business Overview

6.4.2. Product and Service Offering

6.4.3. Financial Overview

6.4.4. SWOT Analysis

6.4.5. Strategic Developments

6.5. Tenax Therapeutics

6.5.1. Business Overview

6.5.2. Product and Service Offering

6.5.3. Financial Overview

6.5.4. SWOT Analysis

6.5.5. Strategic Developments

6.6. Ischemix Inc

6.6.1. Business Overview

6.6.2. Product and Service Offering

6.6.3. Financial Overview

6.6.4. SWOT Analysis

6.6.5. Strategic Developments

6.7. Vasopharm GmbH

6.7.1. Business Overview

6.7.2. Product and Service Offering

6.7.3. Financial Overview

6.7.4. SWOT Analysis

6.7.5. Strategic Developments

6.8. Amarantus BioScience Holdings

6.8.1. Business Overview

6.8.2. Product and Service Offering

6.8.3. Financial Overview

6.8.4. SWOT Analysis

6.8.5. Strategic Developments

6.9. Silver Creek Pharmaceuticals Inc

6.9.1. Business Overview

6.9.2. Product and Service Offering

6.9.3. Financial Overview

6.9.4. SWOT Analysis

6.9.5. Strategic Developments

6.10. Stemedica Cell Technologies Inc

6.10.1. Business Overview

6.10.2. Product and Service Offering

6.10.3. Financial Overview

6.10.4. SWOT Analysis

6.10.5. Strategic Developments

6.11. Banayan Biomarkers Inc.

6.11.1. Business Overview

6.11.2. Product and Service Offering

6.11.3. Financial Overview

6.11.4. SWOT Analysis

6.11.5. Strategic Development

6.12. Abbreviation

Global Traumatic Brain Injuries Treatment Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation Forecast 2024